1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
iLex Medical Ltd.

iLex Medical Ltd.

ILX.TA
iLex Medical Ltd.IL flagTel Aviv Stock Exchange
4,918.00
ILA
+16.00
- -
550.23MMarket Cap
iLex Medical Ltd.
ILX.TA
(Tel Aviv Stock Exchange)

Recent

price

4,918.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
45.98
43.13
49.58
51.71
55.17
59.9
63.17
88.7
94.05
76.54
81.88
82.26
83.2
80.91
Revenue per Share
-2.21
2.2
3.1
2.76
3.73
4.68
6
11.3
17.51
9.05
4.55
3.48
4.97
4.59
Basic EPS, GAAP
0.28
6.79
1.99
-0.19
5.47
3.4
5.34
12.75
20.21
3.67
2.53
4.32
3.83
5.03
Free Cash Flow per Basic Share
0.08
1.84
- -
1
1.49
1.79
2.49
- -
5.32
5.32
1.92
1.36
1.22
1.22
Dividend per Share
- -
8.92
12.05
13.84
16.03
18.96
22.46
32.53
42.98
46.8
49.81
51.94
55.71
54.11
Book Value per Share
- -
11.47
16.07
18.75
21.53
24.96
28.55
38.59
48.72
51.51
53.19
55.63
59.51
57.94
Tangible Book Value per Share
10
10
10
10
10
10
10
11
11
11
11
11
11
11
Basic Weighted Avg Shares
461
433
497
519
554
601
634
946
1,061
863
916
920
931
906
Sales/Revenue/Turnover
-4.87
7.84
7.16
7.46
8.65
12.26
11.69
15.29
23.03
16.78
8.47
7.03
6.01
5.5
Operating Margin (%)
21
21
22
22
24
25
37
40
50
50
48
49
50
50
Depreciation Expense
-22
22
31
28
37
47
60
121
197
102
51
39
56
51
Net Income, GAAP
- -
38.46
25.09
25.94
26.18
22.86
24.51
18.1
22.66
24.18
25
25.8
25.06
25.81
Effective Tax Rate (%)
-4.81
5.11
6.25
5.33
6.76
7.82
9.5
12.74
18.61
11.83
5.55
4.24
5.97
5.67
Profit Margin (%)
- -
129
148
157
173
195
198
280
392
409
407
451
468
428
Working Capital
- -
98
70
61
45
36
53
43
46
39
36
39
33
36
LT Debt
- -
205
226
245
266
293
323
444
576
613
624
646
685
666
Total Equity
- -
11.87
7.73
8.37
10.15
15.84
14.1
25.11
31.7
16.37
8.69
6.98
5.82
5.19
Return on Invested Capital (%)
- -
16.65
10.26
8.15
9.83
12.17
14.74
28.02
41.58
18.4
8.82
6.59
8.78
8.36
Return on Capital (%)
- -
49.39
29.57
21.29
24.96
26.76
29
42.14
47.47
20.17
9.38
6.85
9.23
8.69
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
12
14
13
LT Borrowings
- -
- -
- -
LT Finance Leases
37
33
36
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
75,012
74,810
68,560

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
684
724
652
Cash, Cash Equivalents & STI
240
232
215
Accounts Receivable, Net
228
266
235
Inventories
186
194
183
Total Current Liabilities
239
255
224
Payables & Accruals
- -
- -
- -
ST Debt
12
14
13
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.22%
9.52%
5.91%
Free Cash Flow
-286.93%
2.72%
-11.36%
Net Income, GAAP
16.26%
-3.12%
42.52%
Sales/Revenue/Turnover
7.55%
0.24%
1.14%
Total Cash Common Dividend
- -
7.26%
-10.63%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
237
214
238
221
920
2025
238
219
228
246
931
2026
214
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.25
0.49
1.16
- -
3.48
2025
0.81
1.51
0.98
- -
4.97
2026
0.44
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
1.36
- -
- -
1.36
2025
- -
1.22
- -
- -
1.22
2026
- -
- -
- -
- -
- -
Similar Companies
J Frontier Co., Ltd. (2934.T)
Ebos Group Limited (EBO.NZ)
Functional Brands, Inc. Common Stock (MEHA)
Sinopharm Group Co. Ltd. (SHTDF)
McKesson Corporation (0JZU.L)
DocCheck AG (AJ91.DE)
Business
Ilex Medical Ltd (ILX.TA) is an Israel-based supplier of in vitro diagnostic equipment, laboratory management software, and healthcare technological solutions. The company engages in the import, marketing, distribution, and sale of diagnostic products, kits, and consumables; microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions; coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine, occult blood, and calprotectin services; as well as LIS, urine microscopy, osmolarity, and genetic laboratory services. It also provides medical automation solutions for microbiology, immunoserology, chemistry, hematology, and coagulation; medical equipment for pain management, endoscopy systems, digestive health, cardiology, vascular interventions, radiology, care wards, radiotherapy, urology, ophthalmology, anesthesia, respiratory care, and women's health; oncogenetics, pharmacogenetics, pregnancy checks, and genetic disease testing services; single cell analysis, microbiome, epigenetics, gene expression, bioinformatics, molecular diagnostics, automated and manual DNA/RNA, and liquid biopsy solutions; and clinical ventilation products such as Vento2ux and Flight 60. Founded in 1977 and headquartered in Petah Tikva, Israel, Ilex Medical operates primarily in Israel and South Africa, with international reach, through segments including medical laboratory equipment and diagnostics materials, medical equipment, and inhalation devices; its South African subsidiary, ILEX South Africa Pty Ltd, was established in 1992 and is based in Woodmead, Gauteng. In recent developments, the company reported earnings results for the second quarter and six months ended June 30, 2025, reflecting ongoing operational performance in the healthcare distribution sector.